ISMPP have presented the results of their poll into whether pharmaceutical companies will allocate internal resources to the development of lay summaries.
Of 240 responses, 144 (60%) said ‘yes’. 8.8% reportd that they were unsure. Presumably this means that the remaining 31.3% will outsource the development of their lay summaries?
Results available here